Mind how you go : The current strategies for the development of therapies for Alzheimer's disease are very diverse. Particular attention is given to the search for inhibitors (see picture for two examples) of the proteolytic enzyme β‐ and γ‐secretase, which inhibits the cleavage of the amyloid precursor proteins into amyloid β peptides, from which the disease‐defining deposits of plaque in the brains of Alzheimer's patients originates.